Flexibility for Your Patients
Self-administration gives you and your patients the freedom to choose:
Your patient's routine
How long infusions take
How much medicine per infusion
How many infusion sites
Hizentra is indicated for the treatment of primary immune deficiency (PI) in adults and pediatric patients 2 years older, and for maintenance therapy in adults with chronic inflammatory demyelinating polyneuropathy (CIDP) to prevent relapse of neuromuscular disability and impairment.
Frequently asked questions about Hizentra
Want to know more about Hizentra? We have the answers to prescribers' frequently asked questions.
See the answersHizentra dosing and administration
Explore helpful tools for and additional information about self-infusing Hizentra.
See dosing options and administration